Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions highlight a strong consensus on the ineffectiveness of hydroxychloroquine, with many referencing randomized controlled trials and using emphatic phrases like 'no benefit' and 'not effective' to convey their views. Phrases like 'another negative trial' illustrate a frustration with the ongoing debate, while many contributors are quick to share scientific studies to support their arguments, indicating both the tone of urgency and seriousness surrounding the topic.
Most posts express strong support for the conclusions that hydroxychloroquine is ineffective.
This topic has generated high curiosity, seeing extensive discussion and references across multiple platforms.
Many users engage deeply with the scientific findings, referencing specific studies and their results.
The community perceives that the publication has a significant effect on public health discussions.
@RealPNavarro @mtgreenee @CC @JohnBerman @CNN Psst, Peter! HCQ is not an effective COVID treatment. This has been shown over and over with randomized control trials. https://t.co/bGIROu8FjQ https://t.co/fv1h15G5JE https://t.co/i31d9ekRqE https://t.co/9njjjfSMQx https://t.co/n7qZSLkjLp
@Pedrophd06 @RevistaEpoca como o brasileiro só lê notícias, é importante ressaltar que devamos procurar artigos científicos e não nos embasar apenas por notícias. 2 dos vários artigos que comprovam a ineficácia da hcq https://t.co/YQiJOB0M6L https://t.co/kPjv6ZWBHG
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection https://t.co/fYcwqdMvBY https://t.co/wyI47rmORU
Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq
#Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. Read more https://t.co/7gncMvyygv. #COVID19 https://t.co/SRs6Sz1sug
This video analyzes six randomized trials that explore the clinical outcomes of distinct treatment groups for hydroxychloroquine (HCQ) in COVID-19. Findings reveal no significant differences in infection rates, with HCQ…
@TrialsiteN https://t.co/4TRjtOngTw
https://t.co/4TRjtOngTw
@mothrfunkr https://t.co/4TRjtOngTw
@mothrfunkr https://t.co/4TRjtOngTw
@DopplerEffect93 @DrNeilStone I was referring to this study. Consider it a lesson in mendacity. https://t.co/dLX5JNvS2r
@StevePascolo @fluidloading @AlaryPatrick @gkierzek https://t.co/5CIjzXZvKr
@WellKnitTech 11/N https://t.co/izRp83OK0S
@StevePascolo @Florian_Boeglin @RegreenSahara Comme ce RCT en prophylaxie low dose? https://t.co/5CIjzXZvKr
#Mystifications However, on the basis of our data and that of others, the conclusion that #Hydroxychloroquine is ineffective for SARS-CoV-2 prevention is most reasonable. https://t.co/3n8WPyKYQg
"Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial - PubMed" https://t.co/KOWDEEvwwx
@BarryESharp @Sixxwitch1 @Doctor_Eric_B @TheLancet Cool, you can take a look at a myriad of articles from other reputable journals, such as this one. I’m not gonna argue about this with someone that keeps sending the same things over and over. I sleep well at night knowing I trust science. https://t.co/uNBMT2NCPd
@HoowlingWolf @DropaGoldenSun @healthbyjames I'm guessing you didn't bother to actually look up ivermectin or hydroxychloroquine results either. Here you go, illiterate one. https://t.co/T7TKOzk86m https://t.co/TEr0DVLCVi https://t.co/0bHiuY79Ob https://t.co/D6TyVGjsEf https://t.co/aO1oYxurrE
@sudokuvariante @OsonsCauser @humanite_fr Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@Zenon71647295 @giranthon @Christi67158123 INSTRUISEZ VOUS! Etudes RANDOMISEES : 4 / 15 https://t.co/rnZk3Nw4R0 https://t.co/F2NZsyGJZV https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR
@Tsadqiell @Esban_ Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@OunetPik @r_cluz @CocoCocoCocoVi1 @clouzeau_b Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF Bonne lecture.
@r_cluz @Lspjerem @CocoCocoCocoVi1 @clouzeau_b sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@canyon_free @sorrow79 @mtgreenee Here is a fifth study know show any efficacy. Amazing how many studies have not replicated Zelenkos results. https://t.co/mNfEZFvFTG
@Symptezia @obourdais @raoult_didier Sinon, pour repondre a la question initiale, ici un RCT, prophylaxie, low dose en hcq. See the conclusion https://t.co/5CIjzXZvKr https://t.co/rjgRcERyWz
RT @Autarkh: @RealPNavarro @mtgreenee @CC @JohnBerman @CNN Psst, Peter! HCQ is not an effective COVID treatment. This has been shown over…
@Morgant54525028 @David_Havan @sandrafellous_ Etudes RANDOMISEES : https://t.co/F2NZsyGJZV https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0
@yet34284753 @CBarrely ETUDES RANDOMISEES https://t.co/F2NZsyGJZV https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0
@NaZa_on @LazzariAmbrogio @MGrecoMD @vadoaberlino @GiacomoGorini https://t.co/F6Kmd8eBi8 https://t.co/6vjfFRxt23 https://t.co/Xt6OtNx4M7 https://t.co/l46ArRAx26 giusto qualcuno, ma ne è piena la letteratura.
@dapstats @rocket_jenross @PharmGuySB @traderjrae @cppinvest @andykatz19 @kimgits1 @amlivemon @RebornCaz Support for an IND is a long way from actual clinical significance. Sorry, science says HCQ doesn't work. Couple more on prophylaxis for you: https://t.co/27RBYw1HoR https://t.co/8xBmnwIuNE
@dapstats @rocket_jenross @PharmGuySB @traderjrae @cppinvest @andykatz19 @kimgits1 @amlivemon @RebornCaz The 2005 paper, beloved of HCQ fans, is close to meaningless. Wrong drug (CQ vs. HCQ); wrong species (monkey cells, not humans). There's plenty of recent evidence that HCQ is worthless for prophylaxis in the real world. https://t.co/27RBYw1HoR https://t.co/4axDOTw0J3
@JenniferLoya19 @soylentbeige @empath_angry @StmCh_ Please read the scientific studies. HCQ does not stave off Covid. https://t.co/27RBYw1HoR https://t.co/xYNzg2gDZR
@OsonsCauser @Thinker_View @LMucchielli https://t.co/1npa1MraZx https://t.co/CHt6RMerLH https://t.co/ebHstUovIp https://t.co/4aldbmMotu https://t.co/e97br8mTRI pas d'azithromycine poubelle.
@TRACEYBTHIERRY @Erik44187887 @DIVIZIO1 Et ça c est des coups bas ??? ETUDES RANDOMISEES ( 14) https://t.co/F2NZsyGJZV https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0
@Sandrabon14 @crespo6047 @bloodworse @COV_COPPERFIELD Sur la potion de Raoult: Si tu vraiment t instruire sur le sujet HCQ, voici une liste de meta analyses et d etudes RANDOMISEES...je dis bien RANDOMISÉES...et non pas observationnelles. https://t.co/F2NZsyGJZV https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR
RT @Autarkh: @RealPNavarro @mtgreenee @CC @JohnBerman @CNN Psst, Peter! HCQ is not an effective COVID treatment. This has been shown over…
RT @Autarkh: @RealPNavarro @mtgreenee @CC @JohnBerman @CNN Psst, Peter! HCQ is not an effective COVID treatment. This has been shown over…
RT @Autarkh: @RealPNavarro @mtgreenee @CC @JohnBerman @CNN Psst, Peter! HCQ is not an effective COVID treatment. This has been shown over…
@RealPNavarro @mtgreenee @CC @JohnBerman @CNN Psst, Peter! HCQ is not an effective COVID treatment. This has been shown over and over with randomized control trials. https://t.co/bGIROu8FjQ https://t.co/fv1h15G5JE https://t.co/i31d9ekRqE https://t.co/9njjjfSMQx https://t.co/n7qZSLkjLp
@terri911065 @Jim_Jordan >[something something] HCQ [something something] I'm done. Have a good day. Enjoy the Qlorox. https://t.co/fv1h15G5JE https://t.co/i31d9ekRqE https://t.co/9njjjfSMQx https://t.co/n7qZSLkjLp https://t.co/s9y1MG5oP7
@burel7 @LMucchielli 1/ ETUDES RANDOMISEES https://t.co/F2NZsyGJZV https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0
@debora_badaro @WHO Ineficácia Hidroxicloroquina: Profilaxia pós-exposição (randomizado, duplo-cego, controlado): https://t.co/7ZeRmw4feO https://t.co/O4T52LPZHK Pacientes hospitalizados (randomizado, open label e controlado): https://t.co/Gp38p99Cef Revisão sistemática: https://t.co/LIaJSwSH6N
@RosaVolkmann @edu_1105 @silberhautchen @TheInterceptBr @romulismo @mab_sp125 @MBittencourtMD @schrarstzhaupt Ineficácia Hidroxicloroquina: Profilaxia pós-exposição (randomizado, duplo-cego, controlado): https://t.co/7ZeRmw4feO https://t.co/O4T52LPZHK Pacientes hospitalizados (randomizado, open label e controlado): https://t.co/Gp38p99Cef Revisão sistemática: https://t.co/LIaJSwSH6N
@felipejsch Ineficácia da Hidroxicloroquina: Profilaxia pós-exposição (randomizado, duplo-cego, controlado): https://t.co/j2xTJajKZV https://t.co/EntmOJWEa0 //3
"excluded a clinically meaningful effect of hydroxychloroquine as postexposure prophylaxis to prevent SARS-CoV-2 infection" https://t.co/9I5TlnINeX
Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq
New article: Correction: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection https://t.co/SX5Fwi63mw #coronavirus #COVID19 #2019ncov https://t.co/GaYEFPBCNx
Rigorous trial shows no effect of hydroxychloroquine as Postexposure Prophylaxis to Prevent SARS-CoV2 Infection: @AnnalsofIM @AnnaBershteyn et al March 2021 https://www-acpjournals-org/doi/10.7326/M20-6519#.YE_YcvwuSoM.twitter
@dariosa34 @lady_sud @cunegonde1944 Plutot l'inverse: ou peut t'on trouver des études qui prouvent que l'HCQ marche? Il n'y en a plus... Une petite dernière: https://t.co/YCbO0piGKq "No difference was found between the two study groups."
@IBela2405 @larszahng @jpoliverx @detectivcomiccs @PedroLothBrok https://t.co/6NgO7kpHtX https://t.co/vDqdgCdntR Resumo de um estudo falando sobre como a cloroquina não previne COVID https://t.co/1dP4OWco4b O estudo que o artigo acima cita: https://t.co/E6aoyZJN7G
@wouterkeller Vreemd. In sommige studies zie je een significant verschil. Er wordt in de studies niet ingegaan op het ziektebeeld. Geen van de studies vermeld toevoeging Zinc. Een minder vriendelijke studie in het rijtje wordt betaald door Bill en Melinda Gates https://t.co/qEunX1PZCH
@IkNet https://t.co/3sFAEcgovx
@imortalcordoba Ineficácia Hidroxicloroquina: Profilaxia pós-exposição (randomizado, duplo-cego, controlado): https://t.co/7ZeRmw4feO https://t.co/O4T52LPZHK Pacientes hospitalizados (randomizado, open label e controlado): https://t.co/Gp38p99Cef Revisão sistemática: https://t.co/LIaJSwSH6N
@24_gogol @Mr_Rible @boutaour @raoult_didier @france_soir Tiens voilà pour toi Gogol et bonne lecture! 1/ 8 ETUDES RANDOMISEES https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0 https://t.co/XciNPi0Yv3
@CemoiLefreb @boutaour @raoult_didier @france_soir 1/3 ETUDES RANDOMISEES https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0 https://t.co/XciNPi0Yv3
@brunobd11 @NuezMichal1 @chismeres @jclacio2 @Libre__Dz @raoult_didier @IHU_Marseille https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0
@grox57 @littleb1gman @Athilhunt @MyriamArnaux1 @raoult_didier @IHU_Marseille https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0 https://t.co/XciNPi0Yv3
@littleb1gman @GregMeyerlapec @FJung100 @Athilhunt @MyriamArnaux1 @raoult_didier @IHU_Marseille https://t.co/XuOaOG0eRZ https://t.co/MTNenD3saR https://t.co/aIyhYzOgQ0 https://t.co/XciNPi0Yv3
@Michel88631131 @ALBrasilCM @josegallucci @MBittencourtMD Trazendo aqui estudos, como tu pediu: 1 - https://t.co/7ZeRmw4feO 2 - https://t.co/Gp38p99Cef 3 - https://t.co/MlLP3re7EI
RT @umteteko: @Pedrophd06 @RevistaEpoca como o brasileiro só lê notícias, é importante ressaltar que devamos procurar artigos científicos e…
@Pedrophd06 @RevistaEpoca como o brasileiro só lê notícias, é importante ressaltar que devamos procurar artigos científicos e não nos embasar apenas por notícias. 2 dos vários artigos que comprovam a ineficácia da hcq https://t.co/YQiJOB0M6L https://t.co/kPjv6ZWBHG
@TiagoDi59122897 @brcartelli @Petrovarius @RDL2001 https://t.co/gsVjcYEpdP
@reiscristiano98 @Petrovarius @RDL2001 https://t.co/gsVjcYEpdP
@banlieue75 @nathanpsmad @BdLVillardiere Voici une liste non exhaustive d etudes en.prophylaxie. 0 effet. https://t.co/o7BrMPk0CN https://t.co/XuOaOG0eRZ https://t.co/oL7BwgIykC
@MateusMadeira12 @AdilsonAlves_Jr @arthurmoledoval Annals of Internal Medicine não é confiável? https://t.co/f90KccOyey Swiss Medical Weekly tbm não é confiável? https://t.co/mfV2UerCJn Travel Medicine and Infectious Disease tbm não é uma boa fonte? https://t.co/6f9cf67DFA oxford tbm é uma porcaria? https://t.co/u2hahlEbSq
@to_kyo_373 @DI360SCH @Pedrophd06 @arthurmoledoval Annals of Internal Medicine https://t.co/f90KccOyey Swiss Medical Weekly https://t.co/mfV2UerCJn Travel Medicine and Infectious Disease https://t.co/6f9cf67DFA oxford https://t.co/u2hahlEbSq Estão todos naquele link...... É só escolher dentre os quase 200 e abrir a fonte
@to_kyo_373 @DI360SCH @Pedrophd06 @arthurmoledoval Annals of Internal Medicine não é confiável? https://t.co/f90KccOyey Swiss Medical Weekly tbm não é confiável? https://t.co/mfV2UerCJn Travel Medicine and Infectious Disease tbm não é uma boa fonte? https://t.co/6f9cf67DFA oxford tbm é uma porcaria? https://t.co/u2hahlEbSq
@AdilsonAlves_Jr @arthurmoledoval Annals of Internal Medicine não é confiável? https://t.co/f90KccOyey Swiss Medical Weekly tbm não é confiável? https://t.co/mfV2UerCJn Travel Medicine and Infectious Disease tbm não é uma boa fonte? https://t.co/6f9cf67DFA oxford tbm é uma porcaria? https://t.co/u2hahlEbSq
@AdilsonAlves_Jr @arthurmoledoval Annals of Internal Medicine não é confiável? https://t.co/f90KccOyey Swiss Medical Weekly tbm não é confiável? https://t.co/mfV2UerCJn Travel Medicine and Infectious Disease tbm não é uma boa fonte? https://t.co/6f9cf67DFA oxford tbm é uma porcaria? https://t.co/u2hahlEbSq
@pasqua761 @GovChinesNao @101_bonoro @thiago72571312 @arthurmoledoval Annals of Internal Medicine não é confiável? https://t.co/f90KccOyey Swiss Medical Weekly tbm não é confiável? https://t.co/mfV2UerCJn Travel Medicine and Infectious Disease tbm não é uma boa fonte? https://t.co/6f9cf67DFA oxford tbm é uma porcaria? https://t.co/u2hahlEbSq
@101_bonoro @GovChinesNao @thiago72571312 @arthurmoledoval https://t.co/f90KccOyey tem esse da Annals of Internal Medicine mas se mesmo assim estiver complicado, tem esse da LANCLET considerando um DUPLO CEGO RANDOMIZADO https://t.co/ZKkefIe3dR
@AdilsonAlves_Jr @arthurmoledoval https://t.co/f90KccOyey as vezes a oxford tbm possa ser uma fonte confiável pra vc https://t.co/KaN0XWSfYF
https://t.co/0mg5kGC2Mj https://t.co/a5vb98fEqM
Hydroxychloroquine shown ineffective for postexposure prophylaxis to prevent SARS-Cov-2 infection in robust randomized trial @AnnalsofIM https://t.co/xSnznUm4Oq @AnnaBershteyn, Lorna Thorpe et al @nyulangone @pophealthNYC
@epicethanol86 @waywardmegan15 @ConcernedinPV @ziggystardad @SlimJimJohn1 @_Kel_Varnsen_ @ChrisKelly3422 @Flattielover @giddy_bunny @Silver_Strike @EMMYreincarnate @JayEstus @wookietim @QDecoder @JenCages @Emma34770971 @PhilDiagnosis @alshadowdancer @Synyster63 @SBDSoultrain @cbessex @AndrewJacksonV3 @jdd2169 @AlgrenQ @TheOldPoet @GOPkleptocrat @LadyOfTheOcean1 @TomDoubting @BonhommePhilip @JDW714 @JanineVorr @lizstl13 @PFlophaus @MamaLouies @kheru_at @Dominique85_86 @OnsideOrAnother @instinctnaturel @NavyGritzngravy @MrChingonE @yfactor8 @mathmomma24 @LifeNyc2 @Dennisabm @cubancafecito @hof_jim @22CB22CB @tanya_fitch @Deadpools_R_Us @PatriotsWon2020 Results in Open Forum Infectious Diseases show hydroxychloroquine does not protect people from the novel coronavirus. https://t.co/jYwwR6BSoI
Hydroxychlorquine, une autre étude négative : Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0 https://t.co/fgccB3acud
@laguiloute @emma_ducros Ça par exemple. Mais il y en a plei' d'autres... New england journal of medecine (https://t.co/iStmYjH6cg), Annals of internal medecine (https://t.co/qzgwK93wNw). On a perdu tellement de temps à étudier et reetudier la même chose sans résultat. Passons à autre chose !
RT @EricTopol: I know it must be hard to believe. Another negative randomized trial for hydroxychloroquine for preventing #COVID19 @Annalso…
RT @EricTopol: I know it must be hard to believe. Another negative randomized trial for hydroxychloroquine for preventing #COVID19 @Annalso…
RT @EricTopol: I know it must be hard to believe. Another negative randomized trial for hydroxychloroquine for preventing #COVID19 @Annalso…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
RT @AnnalsofIM: #Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. R…
#Hydroxychloroquine should not be used to prevent SARS-CoV-2 infection after exposure to a close contact with infection. Read more https://t.co/7gncMvyygv. #COVID19 https://t.co/SRs6Sz1sug
@DarthIuri https://t.co/hJi9hEBciQ
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
@LFoues @Tipuncho @idrissaberkane Le site c19study a été débunké maintes et maintes fois. Côté étude là vite fait je peux vous citer ces deux là par exemple : New england journal of medecine (https://t.co/nfQxreAAtc), Annals of internal medecine (https://t.co/X3zNIn44av). Vous en voulez d'autres ?
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
@EduardoBfr2 @RoselyBodart @LuizverasVeras @CrisBernart Vou mandar só um estudo pq tenho preguiça de gente limitada. https://t.co/FKP8ZvzMNs
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0 https://t.co/gVY2XQtzYE
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @uwdgh: New study results out in @AnnalsofIM show that hydroxychloroquine does not protect people from the novel coronavirus. Ruanne Bar…
@takeheight7 @DirkDig40017971 @Zulu18360299 @ordrespontane @ScornDes @ReinfoCovid Voici des liens vers des études randomisées qui démontrent l'inefficacité de l'HCQ avec ou sans AZT : Nature (https://t.co/pmgKBQc1w7), New england journal of medecine (https://t.co/iStmYjH6cg), Annals of internal medecine (https://t.co/qzgwK93wNw). Vous en voulez d'autres ?
Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19 – via @AnnalsofIM https://t.co/q1jJVkyvJG Summary for Patients: https://t.co/BNbia7AdEF
RT @EricTopol: I know it must be hard to believe. Another negative randomized trial for hydroxychloroquine for preventing #COVID19 @Annalso…
RT @EricTopol: I know it must be hard to believe. Another negative randomized trial for hydroxychloroquine for preventing #COVID19 @Annalso…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. https://t.co/M3IxpTzIRz
Randomized controlled trial among persons with recent exposure excluded a clinically meaningful effect of hydroxychloroquine as postexposure prophylaxis to prevent SARS-CoV-2 infection https://t.co/QSjFOPJWJf
RT @n_lapidus: Nouvel essai sur l'HCQ en prophylaxie, avec cette fois une différence significative mettant en évidence un effet pharmacolog…
"This rigorous randomized controlled trial among persons with recent exposure excluded a clinically meaningful effect of #hydroxychloroquine as postexposure prophylaxis to prevent SARS-CoV-2 infection." https://t.co/y2weGEVpwo
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
Another day and yet another randomized controlled trial showing #Hydroxychloroquine is NOT effective at preventing #COVID19 infection after exposure, but increases harm. Published in @AnnalsofIM today, funded @gatesfoundation. #MedTwitter https://t.co/U4MsidYAl4 https://t.co/nZGYB3x5xi
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @EricTopol: I know it must be hard to believe. Another negative randomized trial for hydroxychloroquine for preventing #COVID19 @Annalso…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @debkotz2: Just in case you were still wondering, #Hydroxychloroquine does not work as a preventive treatment for #COVID19. Randomized t…
RT @AnnalsofIM: New study out in Annals found #hydroxychloroquine shows no benefit for postexposure prophylaxis for preventing SARS-CoV-2 i…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @GilbertDeray: Encore un essai négatif sur l’hydroxychloroquine. Double aveugle, contre placebo en prévention après une exposition au vi…
RT @ElizabethRBrow2: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A…
RT @Clara_Locher: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection https…
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0 https://t.co/gqRUE4VTJr
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @josegallucci:
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @Clara_Locher: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection https…
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
@glaco64 @EricTopol @AnnalsofIM J'attends avec impatience votre article peer-reviewed : "Comments on Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection".
12-8-2020: In an 829-participant clinical trial just released today from the United States, bad news for hydroxychloroquine for treating very early COVID-19. Recent hydroxychloroquine studies can be politically motivated, however: https://t.co/EMHnUJpVai https://t.co/RnVmugflzo
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @Clara_Locher: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection https…
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection https://t.co/fYcwqdMvBY https://t.co/wyI47rmORU
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
Per chi ancora pensa che HCQ sia un opzione spendibile nel COVID19 Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0 https://t.co/fgFL5wk08n
RT @PeterHorby: Sadly another negative trial for HCQ. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Sy…
MORE¡¡¡¡¡ : Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0 https://t.co/hV2fGwb3Bv
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: https://t.co/idveii07uO
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0 https://t.co/BFUAkox0eT
RT @boback: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomiz…
RT @boback: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomiz…
RT @boback: Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomiz…
RT @greg_folkers: Annals of Intern Med: #Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Corona…
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial @AnnalsofIM https://t.co/PxMjWb0vTe
Annals of Intern Med: #Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection #SARSCOV2 #COVID19 https://t.co/nJ5kwxVJr9 https://t.co/81MPowlvkA
Again and again and again! Hydroxychloroquine doesn’t work. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine https://t.co/261yqprd3R